urapidil has been researched along with Myocardial Ischemia in 4 studies
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Urapidil was given intravenously in the emergent treatment to the group of 23 pts in the mean dose of 50 mg." | 5.29 | [Evaluation of the antihypertensive efficacy of urapidil in the treatment of hypertension emergencies]. ( Błaszyk, K; Cieśliński, A; Grajek, S; Mitkowski, P; Popiel, M; Skorupski, W; Wnuk, H, 1995) |
| "Urapidil was a much weaker coronary vasodilator than dipyridamole." | 1.29 | Global and regional haemodynamic effects of urapidil in conscious dogs with chronic coronary artery occlusion. ( Deruyter, HA; Flameng, W; Marcus, MA; Mignolet, K; Miserez, M; Van Aken, HK; van de Velde, M; Wouters, PF, 1994) |
| "Urapidil was given intravenously in the emergent treatment to the group of 23 pts in the mean dose of 50 mg." | 1.29 | [Evaluation of the antihypertensive efficacy of urapidil in the treatment of hypertension emergencies]. ( Błaszyk, K; Cieśliński, A; Grajek, S; Mitkowski, P; Popiel, M; Skorupski, W; Wnuk, H, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Neuhäuser, C | 1 |
| Müller, M | 1 |
| Welters, I | 1 |
| Scholz, S | 1 |
| Kwapisz, MM | 1 |
| Wouters, PF | 1 |
| Marcus, MA | 1 |
| Van Aken, HK | 1 |
| van de Velde, M | 1 |
| Miserez, M | 1 |
| Deruyter, HA | 1 |
| Mignolet, K | 1 |
| Flameng, W | 1 |
| Błaszyk, K | 1 |
| Grajek, S | 1 |
| Skorupski, W | 1 |
| Popiel, M | 1 |
| Wnuk, H | 1 |
| Mitkowski, P | 1 |
| Cieśliński, A | 1 |
| Kern, MJ | 1 |
1 trial available for urapidil and Myocardial Ischemia
| Article | Year |
|---|---|
Effect of isoflurane on echocardiographic left-ventricular relaxation indices in patients with diastolic dysfunction due to concentric hypertrophy and ischemic heart disease.
Topics: Aged; Anesthetics, Inhalation; Anesthetics, Intravenous; Antihypertensive Agents; Cardiovascular Phy | 2006 |
3 other studies available for urapidil and Myocardial Ischemia
| Article | Year |
|---|---|
Global and regional haemodynamic effects of urapidil in conscious dogs with chronic coronary artery occlusion.
Topics: Adrenergic alpha-Antagonists; Animals; Atrial Function, Left; Blood Pressure; Chronic Disease; Colla | 1994 |
[Evaluation of the antihypertensive efficacy of urapidil in the treatment of hypertension emergencies].
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Emergencies; Female; Heart Rate; Humans; Hypertens | 1995 |
Appreciating alpha-adrenergic receptors and their role in ischemic left ventricular dysfunction.
Topics: Adrenergic alpha-Antagonists; Coronary Circulation; Humans; Myocardial Ischemia; Phentolamine; Piper | 1999 |